Detrimental Impact of Chemotherapy Dose Reduction or Discontinuation in Early Stage Triple-Negative Breast Cancer Treated With Pembrolizumab and Neoadjuvant Chemotherapy: A Multicenter Experience.
Clin Breast Cancer
; 2024 Aug 06.
Article
in En
| MEDLINE
| ID: mdl-39198116
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Clin Breast Cancer
Journal subject:
NEOPLASIAS
Year:
2024
Document type:
Article
Country of publication:
Estados Unidos